Advertisement

Comparison of live birth rates after IVF–embryo transfer with and without preimplantation genetic testing for aneuploidies

Published:September 20, 2021DOI:https://doi.org/10.1016/j.rbmo.2021.09.011

      Abstract

      Research question

      Does the use of preimplantation genetic testing for aneuploidies (PGT-A) result in higher live birth rates when compared with both fresh and frozen embryo transfers (FET) not utilizing PGT-A?

      Design

      Retrospective cohort study at a single tertiary centre using inverse probability of treatment weighting (IPTW) to adjust for differences in baseline characteristics between groups.

      Results

      A total of 107 FET using PGT-A from 74 patients, along with 321 fresh and 286 FET not using PGT-A from 381 patients met the inclusion criteria for this study. In the IPTW-adjusted analysis of transfer-level data, PGT-A transfers resulted in a significantly higher live birth rate when compared with both non-PGT-A fresh (49.5% versus 38.6%, P = 0.036) and FET (50.6% versus 35.8%, P = 0.016). When data were analysed per retrieval level, the live birth rate was similar and acceptably high with or without PGT-A (63.7% versus 52.3%, P = 0.09).

      Conclusion

      When comparing PGT-A to non-PGT-A fresh and FET, PGT-A embryo transfers have a significantly higher live birth rate. However, this difference did not persist at a per-retrieval level. Further investigation is needed to understand in what scenarios PGT-A has clinical significance and whether differences in the number of available embryos for transfer negates the benefit of PGT-A.

      Keywords

      To read this article in full you will need to make a payment

      References

      1. Centers for Disease Control and Prevention, 2019. 2017 Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta, GA: US Department of Health and Human Services.

        • Franasiak J.M.
        • Forman E.J.
        • Hong K.H.
        • Werner M.D.
        • Upham K.M.
        • Treff N.R.
        • Scott R.T.
        The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening.
        Fertil. Steril. 2014; 101: 656-663https://doi.org/10.1016/j.fertnstert.2013.11.004
        • Gleicher N.
        • Kushnir V.A.
        • Barad D.H.
        Is it time for a paradigm shift in understanding embryo selection?.
        Reprod. Biol. Endocrinol. 2015; 13: 3https://doi.org/10.1186/1477-7827-13-3
        • Hatirnaz S.
        • Ozer A.
        • Hatirnaz E.
        • Atasever M.
        • Başaranoglu S.
        • Kanat-Pektas M.
        • Api M.
        Pre-implantation genetic screening among women experiencing recurrent failure of in vitro fertilization.
        Int. J. Gynecol. Obstet. 2017; 137: 314-318https://doi.org/10.1002/ijgo.12135
        • Haviland M.J.
        • Murphy L.A.
        • Modest A.M.
        • Fox M.P.
        • Wise L.A.
        • Nillni Y.I.
        • Sakkas D.
        • Hacker M.R.
        Comparison of pregnancy outcomes following preimplantation genetic testing for aneuploidy using a matched propensity score design.
        Hum. Reprod. 2020; 35: 2356-2364https://doi.org/10.1093/humrep/deaa161
        • Homer H.A.
        Preimplantation genetic testing for aneuploidy (PGT-A): the biology, the technology and the clinical outcomes.
        Aust. New Zeal. J. Obstet. Gynaecol. 2019; 59: 317-324https://doi.org/10.1111/ajo.12960
        • Kang H.J.
        • Melnick A.P.
        • Stewart J.D.
        • Xu K.
        • Rosenwaks Z.
        Preimplantation genetic screening: who benefits?.
        Fertil. Steril. 2016; 106: 597-602https://doi.org/10.1016/j.fertnstert.2016.04.027
        • Mazzilli R.
        • Cimadomo D.
        • Vaiarelli A.
        • Capalbo A.
        • Dovere L.
        • Alviggi E.
        • Dusi L.
        • Foresta C.
        • Lombardo F.
        • Lenzi A.
        • Tournaye H.
        • Alviggi C.
        • Rienzi L.
        • Ubaldi F.M.
        Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cycles.
        Fertil. Steril. 2017; 108 (E3): 961-972https://doi.org/10.1016/j.fertnstert.2017.08.033
        • Munné S.
        • Kaplan B.
        • Frattarelli J.L.
        • Child T.
        • Nakhuda G.
        • Shamma F.N.
        • Silverberg K.
        • Kalista T.
        • Handyside A.H.
        • Katz-Jaffe M.
        • Wells D.
        • Gordon T.
        • Stock-Myer S.
        • Willman S.
        • Acacio B.
        • Lavery S.
        • Carby A.
        • Boostanfar R.
        • Forman R.
        • Sedler M.
        • Jackson A.
        • Jordan K.
        • Schoolcraft W.
        • McReynolds S.
        • Schnell V.
        • Loy R.
        • Chantilis S.
        • Ku L.
        • Frattarelli J.
        • Morales A.
        • Craig H.R.
        • Perloe M.
        • Witz C.
        • Wang W.H.
        • Wilcox J.
        • Norian J.
        • Thompson S.M.
        • Chen S.
        • Garrisi J.
        • Walmsley R.
        • Mendola R.
        • Pang S.
        • Sakkas D.
        • Rooney K.
        • Sneeringer R.
        • Glassner M.
        • Wilton L.
        • Martic M.
        • Coleman P.
        • Shepley S.
        • Mounce G.
        • Griffiths T.
        • Feinberg R.F.
        • Blauer K.
        • Reggio B.
        • Rhinehart R.
        • Ziegler W.
        • Ahmed H.
        • Kratka S.
        • Rosenbluth E.
        • Ivani K.
        • Thyer A.
        • Minter T.
        • Miller C.
        • Gysler M.
        • Saunders P.
        • Casper R.
        • Conway D.
        • Hughes M.
        • Large M.
        • Blazek J.
        • Fragouli E.
        • Alfarawati S.
        Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial.
        Fertil. Steril. 2019; 112 (e7): 1071-1079https://doi.org/10.1016/j.fertnstert.2019.07.1346
        • Murphy L.A.
        • Seidler E.A.
        • Vaughan D.A.
        • Resetkova N.
        • Penzias A.S.
        • Toth T.L.
        • Thornton K.L.
        • Sakkas D.
        To test or not to test? A framework for counselling patients on preimplantation genetic testing for aneuploidy (PGT-A).
        Hum. Reprod. 2019; 34: 268-275https://doi.org/10.1093/humrep/dey346
        • Ozgur K.
        • Berkkanoglu M.
        • Bulut H.
        • Yoruk G.D.A.
        • Candurmaz N.N.
        • Coetzee K.
        Single best euploid versus single best unknown-ploidy blastocyst frozen embryo transfers: a randomized controlled trial.
        J. Assist. Reprod. Genet. 2019; https://doi.org/10.1007/s10815-018-01399-1
        • Paulson R.J.
        Hidden in plain sight: the overstated benefits and underestimated losses of potential implantations associated with advertised PGT-A success rates.
        Hum. Reprod. 2020; 35: 490-493https://doi.org/10.1093/humrep/dez280
        • Penzias A.
        • Bendikson K.
        • Butts S.
        • Coutifaris C.
        • Falcone T.
        • Fossum G.
        • Gitlin S.
        • Gracia C.
        • Hansen K.
        • La Barbera A.
        • Mersereau J.
        • Odem R.
        • Paulson R.
        • Pfeifer S.
        • Pisarska M.
        • Rebar R.
        • Reindollar R.
        • Rosen M.
        • Sandlow J.
        • Vernon M.
        • Widra E.
        The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion.
        Fertil. Steril. 2018; 109: 429-436https://doi.org/10.1016/j.fertnstert.2018.01.002
        • Popovic M.
        • Dhaenens L.
        • Boel A.
        • Menten B.
        • Heindryckx B.
        Chromosomal mosaicism in human blastocysts: the ultimate diagnostic dilemma.
        Hum. Reprod. Update. 2020; 26: 313-334https://doi.org/10.1093/humupd/dmz050
        • Practice Committee and Genetic Counseling Professional Group (GCPG) of the American Society for Reproductive Medicine
        Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion.
        Fertil. Steril. 2020; 114: 246-254https://doi.org/10.1016/j.fertnstert.2020.05.014
        • Quinn M.M.
        • Juarez-Hernandez F.
        • Dunn M.
        • Okamura R.J.
        • Cedars M.I.
        • Rosen M.P.
        Decision-making surrounding the use of preimplantation genetic testing for aneuploidy reveals misunderstanding regarding its benefit.
        J. Assist. Reprod. Genet. 2018; 35: 2155-2159https://doi.org/10.1007/s10815-018-1337-8
        • Roque M.
        • Haahr T.
        • Geber S.
        • Esteves S.C.
        • Humaidan P.
        Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes.
        Hum. Reprod. Update. 2019; 25: 2-14https://doi.org/10.1093/humupd/dmy033
        • Rosen M.P.
        • Johnstone E.
        • McCulloch C.E.
        • Schuh-Huerta S.M.
        • Sternfeld B.
        • Reijo-Pera R.A.
        • Cedars M.I.
        A characterization of the relationship of ovarian reserve markers with age.
        Fertil. Steril. 2012; 97: 238-243https://doi.org/10.1016/j.fertnstert.2011.10.031
        • Rubio C.
        • Bellver J.
        • Rodrigo L.
        • Castillón G.
        • Guillén A.
        • Vidal C.
        • Giles J.
        • Ferrando M.
        • Cabanillas S.
        • Remohí J.
        • Pellicer A.
        • Simón C.
        In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study.
        Fertil. Steril. 2017; 107: 1122-1129https://doi.org/10.1016/j.fertnstert.2017.03.011
        • Schmutzler A.G.
        Theory and practice of preimplantation genetic screening (PGS).
        Eur. J. Med. Genet. 2019; 62103670https://doi.org/10.1016/j.ejmg.2019.103670
        • Sciorio R.
        • Dattilo M.
        PGT-A preimplantation genetic testing for aneuploidies and embryo selection in routine ART cycles: time to step back?.
        Clin. Genet. 2020; 98: 107-115https://doi.org/10.1111/cge.13732
        • Tarozzi N.
        • Nadalini M.
        • Lagalla C.
        • Coticchio G.
        • Zacà C.
        • Borini A.
        Male factor infertility impacts the rate of mosaic blastocysts in cycles of preimplantation genetic testing for aneuploidy.
        J. Assist. Reprod. Genet. 2019; https://doi.org/10.1007/s10815-019-01584-w

      Biography

      Emily Sadecki is a fourth year medical student at Mayo Clinic Alix School of Medicine and recent graduate of the Master of Bioethics programme at the University of Pennsylvania.
      Key message
      Although live birth rates are increased with use of preimplantation genetic testing for aneuploidies (PGT-A) compared with non-PGT-A at a transfer level, the differences are no longer statistically significant at a retrieval-level. Further studies are needed to establish which patient groups would benefit from the use of PGT-A.